Cognitive Research Corporation

Pre-clinical

San Francisco, United StatesFounded 2006cogres.com

Cognitive Research Corporation is a US-based, privately held CRO that has supported over 200 CNS clinical trials and contributed to more than 15 NDA submissions with a 95% approval rate. Founded in 2006, the company operates as a strategic partner for biopharma sponsors, offering a full suite of services from trial design and management to data analysis and regulatory submission support. Its model is built on scientific rigor, long-term team stability, and specialized technology like driving simulation for safety assessment, positioning it as a dedicated expert in the complex CNS development landscape.

Founded

2006

Focus

NeuroscienceDigital Health

AI Company Overview

Technology Platform

CRC's platform is its integrated, CNS-specialized clinical trial service model, enhanced by proprietary methodologies like driving simulation for safety assessment and a tailored library of electronic data capture forms for complex CNS endpoints.

Opportunities

Growth is driven by the expanding and complex CNS drug development market, particularly the need for specialized expertise in novel endpoints, digital tools, and adaptive trial designs.

CRC can leverage its deep track record to capture more work from both emerging biotechs and large pharma partners seeking focused CNS capabilities.

Risk Factors

Key risks include dependence on sponsor R&D budgets, intense competition from larger CROs, and the inherent difficulty of CNS trials where high failure rates could impact reputation.

Maintaining its high staff retention and specialized culture while scaling operations is also a critical challenge.

Competitive Landscape

CRC competes with large global CROs (e.g., Syneos, IQVIA) and other specialty providers. Its differentiation lies in being a pure-play CNS CRO with exceptional team stability, scientific leadership deeply embedded in operations, and a proven track record of supporting successful regulatory submissions.